FAM3B and diabetes mellitus: Given that the increasing incidence of diabetes and subsequent vascular diseases is currently a major public health problem in industrialized countries, inhibition of FAM3B expression in VSMCs may be beneficial for the prevention and therapy of diabetes-associated cardiovascular complications.